Examining lymph node biopsy techniques after chemotherapy in advanced breast cancer patients

Who could benefit from this research

What this research studies

This research investigates the effectiveness of sentinel lymph node biopsy (SLNB) in patients with locally advanced breast cancer who have undergone neoadjuvant chemotherapy. The study aims to determine if SLNB can accurately stage the axilla in these patients, potentially reducing the need for more invasive procedures like axillary lymph node dissection. By utilizing advanced mapping techniques and focusing on patients with limited axillary nodal metastases, the research seeks to minimize complications such as lymphedema. Participants will be monitored for accuracy in staging and overall outcomes following their treatment.

Why it matters

Where this research is happening

• Sloan-Kettering Inst Can Research
  New York, United States Active

Researchers

• Principal investigator: Barrio, Andrea — Sloan-Kettering Inst Can Research
• Study coordinator: Barrio, Andrea

Related research

Other NIH-funded projects on the same topics.

• Using a blood test that looks for tumor DNA to monitor early and locally advanced breast cancer

  This project uses a sensitive blood test that looks for tiny bits of tumor DNA to track treatment response in people with early or locally advanced breast cancer.

  NIH research University of Wisconsin-Madison · Madison, United States · NIH-11306078

• Monitoring breast cancer treatment using blood tests for tumor DNA

  This study is looking at how to better treat people with early and locally advanced breast cancer by checking for tiny bits of cancer DNA in their blood, which could help doctors spot any remaining cancer sooner and tailor treatments to each patient, reducing the chance of unnecessary therapies.

  NIH research University of Wisconsin-Madison · Madison, United States · NIH-11136406

• Investigating factors that affect blood tests for early breast cancer detection

  This study is looking at how different ways of collecting and processing blood samples can help improve blood tests that check for early signs of breast cancer, and it's for patients with early or locally advanced breast cancer.

  NIH research University of Wisconsin-Madison · Madison, United States · NIH-10691211

• Magnetic resonance fingerprinting to gauge chemotherapy response in breast cancer

  A patient-facing look at using a special MRI method (MRF) to see early whether breast cancer is responding to preliminary chemotherapy.

  NIH research Case Western Reserve University · Cleveland, United States · NIH-11408782

• Radiomic markers from 3D mammography to predict breast cancer risk across diverse women

  A Mayo Clinic team is testing advanced computer-derived features from 3D mammograms to improve predicting who will develop breast cancer, including diverse groups of women.

  NIH research Mayo Clinic Rochester · Rochester, United States · NIH-11386848

• Improving how the immune system fights advanced breast cancer by relieving tumor pressure

  A breast cancer treatment study tests whether a common blood pressure drug (losartan) can help immune cells get into tumors and work better with immunotherapy.

  NIH research Boston University Medical Campus · Boston, United States · NIH-11379056

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.